{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T01:24:06Z","timestamp":1787361846693,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"DOI":"10.7759\/cureus.114947","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:55:56Z","timestamp":1787360156000},"source":"Crossref","is-referenced-by-count":0,"title":["Declared Inactive Ingredients in US Oral Drug Listings: A Reproducible Census of Prevalence, Labeling Coverage, and Within-Name Variation"],"prefix":"10.7759","author":[{"given":"Brian","family":"Staiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau6753","article-title":"\"Inactive\" ingredients in oral medications","volume":"11","author":"Reker D","year":"2019","unstructured":"Reker D, Blum SM, Steiger C, Anger KE, Sommer JM, Fanikos J, Traverso G. \"Inactive\" ingredients in oral medications. Sci Transl Med. 2019, 11:eaau6753. 10.1126\/scitranslmed.aau6753","journal-title":"Sci Transl Med"},{"key":"ref2","unstructured":"Declared inactive ingredients in U.S. oral drug product listings. a census of 51,065 eligible distinct product NDC listings. (2026). https:\/\/zenodo.org\/records\/21482069."},{"key":"ref3","unstructured":"National Drug Code Directory. (2026). Accessed. July 27, 2026: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/national-drug-code-directory."},{"key":"ref4","unstructured":"DailyMed Structured Product Labeling resources. (2026). Accessed. July 27, 2026: https:\/\/dailymed.nlm.nih.gov\/dailymed\/."},{"key":"ref5","unstructured":"Medications and gluten. (2017). Accessed. July 27, 2026: https:\/\/www.fda.gov\/drugs\/buying-using-medicine-safely\/medications-and-gluten."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007, 370:1453-7. 10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"ref7","unstructured":"Other open analysis code and computed tables for a reproducible census of declared inactive ingredients in U.S. oral drug listings. (2026). https.\/\/zenodo.org\/records\/21515694."},{"key":"ref8","unstructured":"Orange Book preface. (2026). Accessed. July 27, 2026: https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/orange-book-preface."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.970364","article-title":"The health effects of soy: a reference guide for health professionals","volume":"9","author":"Messina M","year":"2022","unstructured":"Messina M, Duncan A, Messina V, Lynch H, Kiel J, Erdman JW Jr. The health effects of soy: a reference guide for health professionals. Front Nutr. 2022, 9:970364. 10.3389\/fnut.2022.970364","journal-title":"Front Nutr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2017.05.072","article-title":"Assessing food allergy risks from residual peanut protein in highly refined vegetable oil","volume":"106","author":"Blom WM","year":"2017","unstructured":"Blom WM, Kruizinga AG, Rubingh CM, Remington BC, Crevel RW, Houben GF. Assessing food allergy risks from residual peanut protein in highly refined vegetable oil. Food Chem Toxicol. 2017, 106:306-13. 10.1016\/j.fct.2017.05.072","journal-title":"Food Chem Toxicol"},{"key":"ref11","unstructured":"Public Law 117-11. (2021). https.\/\/www.congress.gov\/117\/plaws\/publ11\/PLAW-117publ11.pdf."},{"key":"ref12","unstructured":"Federal Register. (2025). https.\/\/www.govinfo.gov\/content\/pkg\/FR-2025-01-16\/pdf\/2025-00830.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/521072-declared-inactive-ingredients-in-us-oral-drug-listings-a-reproducible-census-of-prevalence-labeling-coverage-and-within-name-variation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:55:58Z","timestamp":1787360158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/521072-declared-inactive-ingredients-in-us-oral-drug-listings-a-reproducible-census-of-prevalence-labeling-coverage-and-within-name-variation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.114947","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}